Syndromic Surveillance Reporting | MIPS ACI Transition Measures for 2018 Reporting

This measure was for 2018 MIPS ACI reporting. View 2019 version ->

For use with CEHRT certified to the 2014 edition.

Measure Description

The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit syndromic surveillance data.

Reporting Requirements

To meet this measure, MIPS eligible clinicians must attest YES to being in active engagement with a public health agency to submit syndromic surveillance data.

Definition of Terms & Additional Information

Active engagement – The MIPS eligible clinician is in the process of moving towards sending “production data” to a PHA, or is sending production data to a PHA.

Active engagement may be demonstrated in one of the following ways:

• • Option 1 – Completed Registration to Submit Data: The MIPS eligible clinician registered to submit data with the PHA to which the information is being submitted; registration was completed within 60 days after the start of the MIPS performance period; and the MIPS eligible clinician is awaiting an invitation from the PHA to begin testing and validation. This option allows MIPS eligible clinicians to meet the measure when the PHA has limited resources to initiate the testing and validation process. MIPS eligible clinicians who have registered in previous years do not need to submit an additional registration to meet this requirement for each MIPS performance period.
• • Option 2 – Testing and Validation: The MIPS eligible clinician is in the process of testing and validation of the electronic submission of data. MIPS eligible clinicians must respond to requests from the PHA; failure to respond twice within a performance period would result in the MIPS eligible clinician not meeting the measure.
• • Option 3 – Production: The MIPS eligible clinician has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA.